Additionally, FDA also approved the ribociclib and letrozole co-pack (Kisqali Femara Co-Pack ... A daily oral dose of 400 mg ...

Use Azithromycin 5 Day Dose Pack (Oral) exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. Follow all ...

The US regulator is to hasten development of Novartis’ Kisqali in premenopausal women ... and were managed through dose interruptions or reductions. This year has seen a rapid rise in the ...

Novartis posted third-quarter results that beat analysts' estimates and raised its full-year outlook, buoyed by strong sales of drugs like breast-cancer treatment Kisqali. The Swiss pharmaceutical ...

Novartis' CDK4/6 inhibitor Kisqali has claimed a broad FDA approval in early breast cancer that could give it an edge over class rival Verzenio from Eli Lilly. The US regulator has cleared Kisqali ...

The FDA recently expanded the approval of the breast cancer drug Kisqali to treat patients with earlier stages of the disease. Thousands of women diagnosed with early-stage breast cancer will have ...

Data from the pivotal trial also showed that the safety profile of Kisqali at the 400mg dose was well-tolerated, with generally low-grade symptomatic adverse events. The European Commission (EC ...

Novartis said the European Medicines Agency has recommended its Kisqali cancer drug for market authorization. The drugmaker said Friday that the EMA's Committee for Medicinal Products for Human ...

“If approved, Kisqali could provide an effective and tolerable adjuvant treatment option to mitigate the risk of recurrence in a broader patient population, particularly for patients who ...

Use Azithromycin 3 Day Dose Pack (Oral) exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. Follow all ...

It can be taken with or without food. A daily oral dose of 400 mg is recommended. The common side effects associated with Kisqali medicine are low white blood cell count or neutropenia.